Dengue Virus Inhibition Targets: A Review and Docking Study

Author(s): Luciana Scotti*, Marcus Tullius Scotti, Nagendra Sastry Yarla, Alex France Messias Monteiro, Jessika de Oliveira Viana, Derli Ranieri Costa Dantzger, Hamilton Mitsugu Ishiki

Journal Name: Current Topics in Medicinal Chemistry

Volume 18 , Issue 18 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Dengue like any neglected tropical disease affects a large part of the world population. In this disease, the infection is caused by arboviruses transmitted by the A. aegypti and A. albopictus mosquito, in which its most severe manifestation is known as dengue hemorrhagic fever. The infected person presents symptoms characteristic of such as fever and rash. Among the ways of fighting dengue by bioactives is the inhibition of NS2B-NS3 protease, inhibition of protein E, and inhibition of sclerotization of the vector cuticle. The cuticle is indispensable for the survival of the mosquito that can be compromised through the inhibition of arylalkylamine N-acetyltransferase (aaNAT). In the studies shown, in silico tests were performed as molecular docking, functional density analysis, molecular orbitals energies with the analyses of the interactions between bioactives and the targets studied. However, in addition to discussing the fight against dengue virus infection through different routes, in this paper, some in silico results of 27 analogs of myricetin have been presented, which showed action on the cuticle sclerotization mechanism.

Keywords: Dengue, NS2B-NS3, aaNAT, Molecular docking, Virus, Neglected tropical disease.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [1522 - 1530]
Pages: 9
DOI: 10.2174/1568026618666181025111605
Price: $65

Article Metrics

PDF: 38